antepsin 1 g tablets
chugai pharma france - sucralfate - tablet - 1 gram(s) - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); sucralfate
antepsin 1 g/5 ml oral suspension
chugai pharma france - sucralfate - oral suspension - 1 g/5ml - other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord); sucralfate
granocyte 13 million iu/ml, powder and solvent for solution for injection/infusion, in a pre-filled syringe
chugai pharma france - lenograstim - powder and solvent for solution for injection/infusion - 13 international unit(s)/millilitre - colony stimulating factors; lenograstim
granocyte 34 million iu/ml, powder and solvent for solution for injection/infusion, in a pre-filled syringe
chugai pharma france - lenograstim - powder and solvent for solution for injection/infusion - 34 million international unit(s)/millilitre - colony stimulating factors; lenograstim
granocyte 13million unit powder and solvent for solution for injection vials
chugai pharma uk ltd - lenograstim - powder and solvent for solution for injection - 13.4mega unit
granocyte 34million unit powder and solvent for solution for injection vials
chugai pharma uk ltd - lenograstim - powder and solvent for solution for injection - 33.6mega unit
granocyte 13 million iu/ml, powder and solvent for solution for injection/infusion, in a pre-filled syringe
chugai pharma uk ltd - lenograstim - powder and solvent for solution for injection/infusion - 105mcg microgram(s) - colony stimulating factors; lenograstim
granocyte 34 million iu/ml, powder and solvent for solution for injection/infusion, in a pre-filled syringe
chugai pharma uk ltd - lenograstim - powder and solvent for solution for injection/infusion - 263mcg microgram(s) - colony stimulating factors; lenograstim
akynzeo
helsinn birex pharmaceuticals ltd - netupitant, palonosetron hydrochloride - vomiting; neoplasms; nausea; cancer - antiemetics and antinauseants, - akynzeo is indicated in adults for the:prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin based cancer chemotherapy.prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
granocyte 13 1 10*6 iu/ml inf. sol. (pwdr. + solv.) s.c./i.v. pre-filled syr. vial
chugai pharma france - lenograstim 105 - powder and solvent for solution for infusion - 1 miu/ml - lenograstim (rhug-csf) 105 µg - lenograstim